May 2016
In this issue Upfront features AC/DC (and microparticles), a new R&D showcase platform, spaceflight for fungi and more. Our cover feature asks what potential impact a Brexit may have on the pharma industry. Best Practice looks at the beginning of the end of Quality by Design and NextGen focuses on the challenges of packaging biologicals. In Profession, we find out the story behind Andrew Lees ‘magical’ career in vaccine conjugation, and Steven Schultz gives his tips for quality writing in the science environment. We also sit down with Ann Hayes, former director of drug discovery at GSK.
Discovery & Development
Business & Trends
Drug Delivery
Formulation
Regulation & Standards
Small Molecules
Bioprocessing
Biopharma
Facilities & Equipment
Technology & Manufacturing
Relative viscosity screening of monoclonal antibody formulations at low concentration and viscosity
May 31, 2016
1 min read
Helping or Hindering Science?
May 17, 2016
Astronomers Chris Leigh and Mike Merrifield debate how a potential Brexit might impact UK science
1 min read
Why the BIA Says No to a Brexit
May 17, 2016
Steve Bates, CEO of the British BioIndustry Association (BIA) explains why he thinks the UK bioindustry is stronger inside the European Union.
1 min read
Language as Quality Control...
May 17, 2016
... or sonicate until the cockroaches disappear. When writing is central to the job of assuring health, safety, and quality, can you afford to be loose with language prone to misunderstanding? Why take a chance? Here are a few strategies to edit your written work for quality control.
1 min read
The Conjuror of Conjugation: Lessons Learned with Andrew Lees
May 17, 2016
Andrew Lees lightheartedly states that he has built his career on two tenets: multivalency and being lazy. And it’s worked out well; while moonlighting as a magician, he has developed the conjugation chemistry behind some of the world's most-used vaccines. Here, he explains how he learned to combine science and magic.
1 min read
Trials and Tribulations
May 17, 2016
Angus Dalgleish tells us about his experience with EU regulation – and why he thinks Britain should leave the EU.
1 min read
Biopharma’s Continuous Future
May 16, 2016
Traditional pharma manufacturers are already dipping their toes in the waters of continuous processing, but what about when it comes to biopharmaceuticals?
1 min read
The Great British Debate
May 16, 2016
As politicians and the public argue over the minor point of the UK leaving Europe, we ask a more important question: what will a “Brexit” mean for the global pharmaceutical industry?
1 min read
Open Door IP
May 16, 2016
Intellectual property issues have suffocated many industry collaborations. And though IP is clearly valuable to pharma companies, there is also value in learning to let go.
1 min read
Beyond Counterfeiting
May 16, 2016
Our experience with implementing serialization, has shown us that anti-counterfeiting is just one of its potential uses.
1 min read
Better Together
May 16, 2016
Antibody drug conjugates offer a great deal of potential for drug targeting, but what’s the best way of linking drugs and antibodies? Indeed, is there a single ‘best way’ in the context of the broad range of antibodies, drugs and diseases to which this modality is applicable?
1 min read
Cancer Static Shock
May 16, 2016
Are the metrics used to measure cancer drug efficacy inherently flawed?
1 min read
Packaging the Future
May 16, 2016
The term ‘packaging’ may not immediately evoke excitement – but without innovation in the field, some therapies wouldn’t even reach market. In other words, don’t judge a box by its cover because there’s more to packaging than meets the eye… and even more lies on the horizon.
1 min read
Space Biology Awakens
May 16, 2016
Can the stress of space force fungi to produce novel therapeutics?
1 min read
CSRxP Vs PhRMA
May 16, 2016
A US coalition seeks lower prices for US prescription drugs, but could their proposals undermine the competitive market?
1 min read
Pharma on a Merger Mission
May 16, 2016
Abbott, Abbvie and Sanofi all make separate merger announcements – on the same day
1 min read
Getting the Message Across
May 16, 2016
What’s the best way to present a health resource? Apparently, ease of use trumps all other factors
1 min read
Hive of Industry
May 16, 2016
Are you a budding biotech or pharma startup? “The Hive” could be your chance to showcase your work
1 min read
Microparticles, You’ve Been Thunderstruck
May 16, 2016
Scientists use hydrophobic plasma and AC/DC’s ‘Thunderstruck’ to coat porous silicon microparticles for drug delivery
1 min read
Doyenne of Discovery
May 16, 2016
Sitting Down With... Ann Hayes, Owner, The Ann Hayes Consultancy, Stevenage, UK.
1 min read
Welcome to (Virtual) Reality
May 16, 2016
VR is creating a buzz, but is it a game changer or gimmick?
1 min read
